Stay updated on 89Zr-Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the 89Zr-Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.9%
    Check dated 2025-06-19T17:21:29.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.2.
    Difference
    1%
    Check dated 2025-06-05T07:42:26.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.15.0 to v2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T14:23:56.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page has been updated to include new information about the study on Non-Small Cell Lung Cancer, specifically mentioning the study's collaborators and a revision update. However, significant details regarding the study's methodology and inclusion/exclusion criteria have been removed.
    Difference
    42%
    Check dated 2025-04-16T11:06:22.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:40:12.000Z thumbnail image
  8. Check
    121 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:48:34.000Z thumbnail image

Stay in the know with updates to 89Zr-Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the 89Zr-Pembrolizumab in NSCLC Clinical Trial page.